Abstract
A new synthetic approach for the antiglaucoma agent, travoprost (1) has been developed in four steps from key intermediate (2). Key transformations include Horner – Wadsworth – Emmons reaction and separation of diastereomers to obtain (±) travoprost (1) and its analogs.
Keywords: Prostaglandins, antiglaucoma, (±) travoprost, Phosphonate, n-BuLi, dimethyl, methane, dimethoxyethane, alkylation
Letters in Organic Chemistry
Title: Synthesis of (±) Travoprost and its Analogs
Volume: 8 Issue: 4
Author(s): Harikrishna Mudduluru, Rama M. Hindupur, Pramod K. Dubey, Shankar Madhavaram, Lakshmikumar Tatini and Gottumukkala V. Subbaraju
Affiliation:
Keywords: Prostaglandins, antiglaucoma, (±) travoprost, Phosphonate, n-BuLi, dimethyl, methane, dimethoxyethane, alkylation
Abstract: A new synthetic approach for the antiglaucoma agent, travoprost (1) has been developed in four steps from key intermediate (2). Key transformations include Horner – Wadsworth – Emmons reaction and separation of diastereomers to obtain (±) travoprost (1) and its analogs.
Export Options
About this article
Cite this article as:
Mudduluru Harikrishna, M. Hindupur Rama, K. Dubey Pramod, Madhavaram Shankar, Tatini Lakshmikumar and V. Subbaraju Gottumukkala, Synthesis of (±) Travoprost and its Analogs, Letters in Organic Chemistry 2011; 8 (4) . https://dx.doi.org/10.2174/157017811795371485
DOI https://dx.doi.org/10.2174/157017811795371485 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Natural Products and their (Semi-)Synthetic Forms in the Treatment of Migraine: History and Current Status
Current Medicinal Chemistry Editorial [Innovative Therapeutic Approaches for the Treatment of Pediatric Autoimmune and Inflammatory Diseases Executive (Guest Editor: Giorgio Zauli)]
Current Pharmaceutical Design S1P Receptor Modulators in Cell Trafficking and Therapeutics
Current Immunology Reviews (Discontinued) Urocortins: Take Them to Heart
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Enhanced Generation of Leukotriene B4 From Calcium Ionophore- Stimulated Rat Peritoneal Inflammatory Cells: A Possible Clinical Relevance
Current Drug Targets - Inflammation & Allergy How to Get from Here to There: Macrophage Recruitment in Alzheimers Disease
Current Alzheimer Research EGF Receptor as a Drug Target in Arterial Hypertension
Mini-Reviews in Medicinal Chemistry Enhancement of Immunoprotective Effect of CpG-ODN by Formulation with Polyphosphazenes Against E. coli Septicemia in Neonatal Chickens
Current Drug Delivery Blood-Brain Barrier and Feeding: Regulatory Roles of Saturable Transport Systems for Ingestive Peptides
Current Pharmaceutical Design Adenosine in the Central Nervous System: Effects on Neurotransmission and Neuroprotection
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Microcirculation Alteration and Biomarker Dilemma in Early Septic Shock Diagnosis and Treatment
Current Vascular Pharmacology Parasites: What are They Good for?
Current Immunology Reviews (Discontinued) Methotrexate Hepatotoxicity in Children with Juvenile Idiopathic Arthritis: A Single-Center Study
Current Rheumatology Reviews Dietary Fatty Acids in Metabolic Syndrome, Diabetes and Cardiovascular Diseases
Current Diabetes Reviews Matrix Metalloproteinases: Drug Targets for Myocardial Infarction
Current Drug Targets Advances in Methods for Therapeutic Peptide Discovery, Design and Development
Current Pharmaceutical Biotechnology Regulation of MET Receptor Signaling by SOCS1 and its Implications for Hepatocellular Carcinoma
Current Pharmaceutical Design HHT in Childhood: Screening for Special Patients
Current Pharmaceutical Design Medicinal and Therapeutic Potential of Herbs and Plant Metabolites / Extracts Countering Viral Pathogens - Current Knowledge and Future Prospects
Current Drug Metabolism Editorial
Inflammation & Allergy - Drug Targets (Discontinued)